Published in Bone Rep on August 16, 2017
Translating the histone code. Science (2001) 56.77
Lysine acetylation targets protein complexes and co-regulates major cellular functions. Science (2009) 20.49
Histone deacetylases (HDACs): characterization of the classical HDAC family. Biochem J (2003) 11.27
Histone acetyltransferases. Annu Rev Biochem (2001) 10.00
The many roles of histone deacetylases in development and physiology: implications for disease and therapy. Nat Rev Genet (2009) 9.68
Histone deacetylase 4 controls chondrocyte hypertrophy during skeletogenesis. Cell (2004) 5.80
Bromodomain: an acetyl-lysine binding domain. FEBS Lett (2002) 5.03
HDAC family: What are the cancer relevant targets? Cancer Lett (2008) 4.17
Runx2 (Cbfa1, AML-3) interacts with histone deacetylase 6 and represses the p21(CIP1/WAF1) promoter. Mol Cell Biol (2002) 2.35
Regulation of global acetylation in mitosis through loss of histone acetyltransferases and deacetylases from chromatin. J Biol Chem (2001) 2.24
Bone morphogenetic protein-2 stimulates Runx2 acetylation. J Biol Chem (2006) 2.15
Histone deacetylase 3 interacts with runx2 to repress the osteocalcin promoter and regulate osteoblast differentiation. J Biol Chem (2004) 1.91
A novel Rho-mDia2-HDAC6 pathway controls podosome patterning through microtubule acetylation in osteoclasts. J Cell Sci (2005) 1.87
Histone acetylation and chromatin remodeling. Exp Cell Res (2001) 1.85
Functional divergence between histone deacetylases in fission yeast by distinct cellular localization and in vivo specificity. Mol Cell Biol (2002) 1.84
Histone H3 acetylation and H3 K4 methylation define distinct chromatin regions permissive for transgene expression. Mol Cell Biol (2006) 1.60
Histone deacetylase inhibitors promote osteoblast maturation. J Bone Miner Res (2005) 1.51
Histone deacetylase 1-mediated histone modification regulates osteoblast differentiation. Mol Endocrinol (2006) 1.42
Histone deacetylase 7 associates with Runx2 and represses its activity during osteoblast maturation in a deacetylation-independent manner. J Bone Miner Res (2008) 1.42
Histone deacetylase inhibitors decrease proliferation potential and multilineage differentiation capability of human mesenchymal stem cells. Cell Prolif (2009) 1.39
Valproate administered after traumatic brain injury provides neuroprotection and improves cognitive function in rats. PLoS One (2010) 1.36
HDAC inhibitor increases histone H3 acetylation and reduces microglia inflammatory response following traumatic brain injury in rats. Brain Res (2008) 1.36
Histone deacetylase inhibitors: a chemical genetics approach to understanding cellular functions. Biochim Biophys Acta (2010) 1.35
Redundant control of adipogenesis by histone deacetylases 1 and 2. J Biol Chem (2010) 1.33
Targeting Hsp90 for the treatment of cancer. Curr Opin Drug Discov Devel (2006) 1.32
HDACi--targets beyond chromatin. Cancer Lett (2009) 1.32
Histone acetylation and chromatin signature in stem cell identity and cancer. Mutat Res (2007) 1.31
Histone deacetylase 3 depletion in osteo/chondroprogenitor cells decreases bone density and increases marrow fat. PLoS One (2010) 1.29
Histone deactylase inhibition combined with behavioral therapy enhances learning and memory following traumatic brain injury. Neuroscience (2009) 1.23
Induction of osteogenic differentiation of human mesenchymal stem cells by histone deacetylase inhibitors. J Cell Biochem (2005) 1.22
Histone deacetylase inhibition with valproic acid downregulates osteocalcin gene expression in human dental pulp stem cells and osteoblasts: evidence for HDAC2 involvement. Stem Cells (2014) 1.19
Histone deacetylases in skeletal development and bone mass maintenance. Gene (2010) 1.16
Histone acetylation in vivo at the osteocalcin locus is functionally linked to vitamin D-dependent, bone tissue-specific transcription. J Biol Chem (2002) 1.16
Transcriptional induction of the osteocalcin gene during osteoblast differentiation involves acetylation of histones h3 and h4. Mol Endocrinol (2003) 1.15
Autoradiographic analysis of odontoblast replacement following pulp exposure in primate teeth. Arch Oral Biol (1990) 1.13
Epigenetic mechanisms that regulate cell identity. Cell Stem Cell (2010) 1.12
NFATc1 mediates HDAC-dependent transcriptional repression of osteocalcin expression during osteoblast differentiation. Bone (2009) 1.11
Zfp521 controls bone mass by HDAC3-dependent attenuation of Runx2 activity. J Cell Biol (2010) 1.10
The epigenetic mechanism of mechanically induced osteogenic differentiation. J Biomech (2010) 1.07
Histone deacetylase inhibitors prevent the degradation and restore the activity of glucocerebrosidase in Gaucher disease. Proc Natl Acad Sci U S A (2011) 1.06
Scaffold design for bone regeneration. J Nanosci Nanotechnol (2014) 1.06
Histone deacetylase 3 is required for maintenance of bone mass during aging. Bone (2012) 1.01
Inhibition of histone deacetylase activity in reduced oxygen environment enhances the osteogenesis of mouse adipose-derived stromal cells. Tissue Eng Part A (2009) 1.01
Mesenchymal dental stem cells in regenerative dentistry. Med Oral Patol Oral Cir Bucal (2012) 0.97
Histone deacetylases in control of skeletogenesis. J Cell Biochem (2007) 0.96
Explorative study on isoform-selective histone deacetylase inhibitors. Chem Pharm Bull (Tokyo) (2009) 0.95
Histone deacetylase inhibitors epigenetically promote reparative events in primary dental pulp cells. Exp Cell Res (2013) 0.92
Effect of the HDAC inhibitor vorinostat on the osteogenic differentiation of mesenchymal stem cells in vitro and bone formation in vivo. Acta Pharmacol Sin (2013) 0.91
Epigenetic mechanisms in bone. Clin Chem Lab Med (2014) 0.86
Histone deacetylase inhibitor trichostatin A promotes the osteogenic differentiation of rat adipose-derived stem cells by altering the epigenetic modifications on Runx2 promoter in a BMP signaling-dependent manner. Stem Cells Dev (2012) 0.85
Histone deacetylase inhibitors induced differentiation and accelerated mineralization of pulp-derived cells. J Endod (2012) 0.83
Histone deacetylase 8 suppresses osteogenic differentiation of bone marrow stromal cells by inhibiting histone H3K9 acetylation and RUNX2 activity. Int J Biochem Cell Biol (2014) 0.83
Epigenetic pathways regulating bone homeostasis: potential targeting for intervention of skeletal disorders. Curr Osteoporos Rep (2014) 0.82
Tackling the epigenome in the pluripotent stem cells. J Genet Genomics (2008) 0.81
HDAC inhibitor trichostatin A promotes proliferation and odontoblast differentiation of human dental pulp stem cells. Tissue Eng Part A (2012) 0.80
Epigenetic modulation of dental pulp stem cells: implications for regenerative endodontics. Int Endod J (2015) 0.78
Promotion of natural tooth repair by small molecule GSK3 antagonists. Sci Rep (2017) 0.78
Histone deacetylase inhibitors: new treatment options for inflammatory joint disease? Joint Bone Spine (2010) 0.77
[Effect of trichostatin A on the osteogenic differentiation potential of periodontal ligament stem cells in inflammatory microenvironment induced by tumor necrosis factor-α stimulation]. Zhonghua Kou Qiang Yi Xue Za Zhi (2016) 0.77
Inhibition of Histone Deacetylases Enhances the Osteogenic Differentiation of Human Periodontal Ligament Cells. J Cell Biochem (2015) 0.76
Analysis of histone deacetylase inhibitor-induced responses in human periodontal ligament fibroblasts. Biotechnol Lett (2012) 0.76
In Vivo Screening Using Transgenic Zebrafish Embryos Reveals New Effects of HDAC Inhibitors Trichostatin A and Valproic Acid on Organogenesis. PLoS One (2016) 0.76
The Histone-Deacetylase-Inhibitor Suberoylanilide Hydroxamic Acid Promotes Dental Pulp Repair Mechanisms Through Modulation of Matrix Metalloproteinase-13 Activity. J Cell Physiol (2016) 0.76
An HDAC Inhibitor, Entinostat/MS-275, Partially Prevents Delayed Cranial Suture Closure in Heterozygous Runx2 Null Mice. J Bone Miner Res (2017) 0.76
Histone deacetylase inhibition enhances in-vivo bone regeneration induced by human periodontal ligament cells. Bone (2016) 0.76